149 related articles for article (PubMed ID: 33816781)
21. Noninvasive longitudinal PET/CT imaging of CAR T cells using PSMA reporter gene.
Song X; Zhang Y; Lv X; Xu Z; Long Y; Gai Y; Jiang D; Lei P; Lan X
Eur J Nucl Med Mol Imaging; 2024 Mar; 51(4):965-977. PubMed ID: 37971500
[TBL] [Abstract][Full Text] [Related]
22. Clutch Control: Changing the Speed and Direction of CAR-T Cell Therapy.
Nobili A; Kobayashi A; Gedeon PC; Novina CD
J Cancer Immunol (Wilmington); 2022; 4(2):52-59. PubMed ID: 36531912
[No Abstract] [Full Text] [Related]
23. Droplet Microfluidics Enables Tracing of Target Cells at the Single-Cell Transcriptome Resolution.
Liu Y; Wang S; Lyu M; Xie R; Guo W; He Y; Shi X; Wang Y; Qi J; Zhu Q; Zhang H; Luo T; Chen H; Zhu Y; Dong X; Li Z; Gu Y; Liu L; Xu X; Liu Y
Bioengineering (Basel); 2022 Nov; 9(11):. PubMed ID: 36354585
[TBL] [Abstract][Full Text] [Related]
24. Development of Anti-LRRC15 Small Fragments for Imaging Purposes Using a Phage-Display ScFv Approach.
Baurand PE; Balland J; Reynas C; Ramseyer M; Vivier D; Bellaye PS; Collin B; Paul C; Denat F; Asgarov K; Pallandre JR; Ringenbach L
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293532
[TBL] [Abstract][Full Text] [Related]
25. Prospective approaches to enhancing CAR T cell therapy for glioblastoma.
Choi SI; Yin J
Front Immunol; 2022; 13():1008751. PubMed ID: 36275671
[TBL] [Abstract][Full Text] [Related]
26. Cellular kinetics: A clinical and computational review of CAR-T cell pharmacology.
Qi T; McGrath K; Ranganathan R; Dotti G; Cao Y
Adv Drug Deliv Rev; 2022 Sep; 188():114421. PubMed ID: 35809868
[TBL] [Abstract][Full Text] [Related]
27. CAR T cell therapy and the tumor microenvironment: Current challenges and opportunities.
Kankeu Fonkoua LA; Sirpilla O; Sakemura R; Siegler EL; Kenderian SS
Mol Ther Oncolytics; 2022 Jun; 25():69-77. PubMed ID: 35434273
[TBL] [Abstract][Full Text] [Related]
28.
Sakemura R; Can I; Siegler EL; Kenderian SS
Mol Ther Oncolytics; 2021 Mar; 20():625-633. PubMed ID: 33816781
[TBL] [Abstract][Full Text] [Related]
29. Development of a Clinically Relevant Reporter for Chimeric Antigen Receptor T-cell Expansion, Trafficking, and Toxicity.
Sakemura R; Bansal A; Siegler EL; Hefazi M; Yang N; Khadka RH; Newsom AN; Hansen MJ; Cox MJ; Manriquez Roman C; Schick KJ; Can I; Tapper EE; Nevala WK; Adada MM; Bezerra ED; Kankeu Fonkoua LA; Horvei P; Ruff MW; Parikh SA; Pandey MK; DeGrado TR; Suksanpaisan L; Kay NE; Peng KW; Russell SJ; Kenderian SS
Cancer Immunol Res; 2021 Sep; 9(9):1035-1046. PubMed ID: 34244299
[TBL] [Abstract][Full Text] [Related]
30. Optimizing Manufacturing Protocols of Chimeric Antigen Receptor T Cells for Improved Anticancer Immunotherapy.
Stock S; Schmitt M; Sellner L
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31835562
[TBL] [Abstract][Full Text] [Related]
31. Anti-CD123 chimeric antigen receptor T-cells (CART): an evolving treatment strategy for hematological malignancies, and a potential ace-in-the-hole against antigen-negative relapse.
Cummins KD; Gill S
Leuk Lymphoma; 2018 Jul; 59(7):1539-1553. PubMed ID: 28901790
[TBL] [Abstract][Full Text] [Related]
32. Influence of Retronectin-Mediated T-Cell Activation on Expansion and Phenotype of CD19-Specific Chimeric Antigen Receptor T Cells.
Stock S; Hoffmann JM; Schubert ML; Wang L; Wang S; Gong W; Neuber B; Gern U; Schmitt A; Müller-Tidow C; Dreger P; Schmitt M; Sellner L
Hum Gene Ther; 2018 Oct; 29(10):1167-1182. PubMed ID: 30024314
[TBL] [Abstract][Full Text] [Related]
33. Quantitative Systems Pharmacology Model of Chimeric Antigen Receptor T-Cell Therapy.
Hardiansyah D; Ng CM
Clin Transl Sci; 2019 Jul; 12(4):343-349. PubMed ID: 30990958
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
